Review
Published on 14 Apr 2021
RIPK2 as a New Therapeutic Target in Inflammatory Bowel Diseases
in Gastrointestinal and Hepatic Pharmacology
- 16,650 views
- 51 citations
Review
Published on 14 Apr 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 12 Apr 2021
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 12 Apr 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 08 Apr 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 31 Mar 2021
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 31 Mar 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 25 Mar 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 25 Mar 2021
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 24 Mar 2021
in Gastrointestinal and Hepatic Pharmacology
Brief Research Report
Published on 18 Mar 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 09 Mar 2021
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 08 Mar 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 04 Mar 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 01 Mar 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 26 Feb 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 25 Feb 2021
in Gastrointestinal and Hepatic Pharmacology